Cargando…
Clinical Features and Long-term Prognosis of Crohn’s Disease in Korea: Results from the Prospective CONNECT Study
BACKGROUND/AIMS: The prospective Crohn’s Disease Clinical Network and Cohort Study is a nationwide multicenter cohort study of patients with Crohn’s disease (CD) in Korea, aiming to prospectively investigate the clinical features and long-term prognosis associated with CD. METHODS: Patients diagnose...
Autores principales: | Hong, Seung Wook, Ye, Byong Duk, Cheon, Jae Hee, Lee, Ji Hyun, Koo, Ja Seol, Jang, Byung Ik, Lee, Kang-Moon, Kim, You Sun, Kim, Tae Oh, Im, Jong Pil, Song, Geun Am, Jung, Sung-Ae, Kim, Hyun Soo, Park, Dong Il, Kim, Hyun-Soo, Huh, Kyu Chan, Kim, Young-Ho, Cha, Jae Myung, Seo, Geom Seog, Choi, Chang Hwan, Song, Hyun Joo, Baik, Gwang Ho, Kim, Ji Won, Shin, Sung Jae, Park, Young Sook, Lee, Chang Kyun, Lee, Jun, Jung, Sung Hee, Jung, Yunho, Park, Sung Chul, Joo, Young-Eun, Jeen, Yoon Tae, Han, Dong Soo, Yang, Suk-Kyun, Kim, Hyo Jong, Kim, Won Ho, Kim, Joo Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668509/ https://www.ncbi.nlm.nih.gov/pubmed/35321956 http://dx.doi.org/10.5009/gnl210299 |
Ejemplares similares
-
Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
por: Choi, Chang Hwan, et al.
Publicado: (2016) -
Comparing the clinical outcomes of young-onset and adult-onset ulcerative colitis: a multi-center Korean Association for the Study for Intestinal Diseases study
por: Kim, Ji Yeon, et al.
Publicado: (2017) -
Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn’s Disease Patients: Results from the CONNECT Study
por: Moon, Chang Mo, et al.
Publicado: (2015) -
Postoperative course of Crohn disease according to timing of bowel resection: Results from the CONNECT Study
por: Lee, Ji Min, et al.
Publicado: (2018) -
Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)
por: Cheon, Jae Hee, et al.
Publicado: (2023)